Cough Syrup

India's drug regulator has directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to have led to the deaths of children in Uzbekistan. Maya Chemtech India Pvt. Ltd. supplied propylene glycol used in Marion Biotech's cough syrups that were found to be "not of standard quality", according to the regulator. Three employees of Marion Biotech were arrested on charges of manufacture and sale of adulterated drugs. Also, the drugs inspector from the Central Drugs Standard Control Organisation (CDSCO) North Zone last week issued a notice to the pharmaceutical firm asking it to stop the sale and distribution of the drug concerned, stating that the sample was found to be "not of standard quality". Uzbekistan alleged in December last year that several children died after consuming Marion Biotech's cough syrups, which it claimed were contaminated with unacceptable amounts of ethyl

Influenza outbreak: According to doctors, this is due to Influenza A subtype H3N2 virus, and it is causing viral fever, common flu, and influenza-like symptoms, including respiratory illness

The process has been initiated for cancellation of the drug license of pharmaceutical firm Marion Biotech, which is allegedly linked with the death of 18 children in Uzbekistan who consumed their cough syrup in December 2022, officials here said on Sunday. All production of drugs and other activities at the firm's campus in Sector 67 here have also been stopped completely, Gautam Buddh Nagar drug inspector Vaibhav Babbar said. On Friday, the local police arrested three senior employees of the firm after an FIR was lodged against them on charges of manufacturing and sale of adulterated drugs. The two directors of the company named in the FIR, however, still remain at large. The process has been initiated for cancellation of the drug license of pharmaceutical firm Marion Biotech. Paperwork for it is in progress and a report has been sent to the Uttar Pradesh government," Babbar told PTI. "All production at the firm had been suspended in January itself and now it has been completely

The company Marion Biotech had supplied the cough syrups that reportedly caused the deaths of Children in Uzbekistan

Catch all the latest updates from across the globe here

Three employees of a city-based pharmaceutical firm Marion Biotech, whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, were arrested on charges of manufacturing and sale of adulterated drugs, officials said. Meanwhile, Drugs Inspector from Central Drugs Standard Control Organization (CDSCO), North Zone, on Friday issued a notice to Marion Biotech asking it to stop the sale and distribution of the drug concerned, stating that the sample was found to be "not of standard quality". "Notice is also hereby issued to you to reply within seven days from the receipt of this letter, why action shall not be taken against you for violation of section 18(a)(i) of the act, failing which it will be presumed that you have nothing to say in this matter and necessary action shall be initiated against you without any further notice," the notice issued on March 3 said. The arrests of three employees were made after an FIR was lodged late Thursday night against

The new investigation strongly suggests that medicines contaminated with the toxins, imported into Gambia, led to the cluster of acute kidney injury among 78 children

The agency seeks more information about the specific raw materials used and whether they were obtained from any of the same suppliers

The WHO has said Marion Biotech had not provided guarantees to them on the safety and quality of these products

The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the results of its controversial cough syrup are awaited, an Uttar Pradesh drug official said Thursday. A team of central agencies and the Uttar Pradesh drug department had carried out an inspection at the firm's office here on December 29 and taken six more samples for testing. During the inspection, the company representatives could not produce documents related to the production of 'Dok-1 max' cough syrup, prompting the government to order halting of its production immediately, Gautam Buddh Nagar Drug Inspector Vaibhav Babbar said. "The production licence of the firm remains suspended, as was ordered on December 29. Now the suspension order has been issued in writing to the firm on January 10 and has been acknowledged by the firm," Babbar told PTI. On the status of the test results, the officer said the samples were taken

"The substandard products referenced in this Alert are unsafe and their use, especially in children, may result in serious injury or death," said WHO

Two of the detained were senior employees of the Scientific Center for Standardization of Medicines, who circumvented the proper testing procedures for the Doc-1 Max cough syrup

Business Standard brings you the top headlines at this hour

Co grew rapidly in the last four-five years; primarily makes cold medication

All manufacturing activities at Marion Biotech's Noida unit have been stopped in view of reports of contamination of its cough syrup, Dok-1 Max, Union Health Minister Mansukh Mandaviya said on Friday. Further investigation in connection with the death of 18 children in Uzbekistan allegedly linked to the cough syrup is going on, the minister said in a tweet. "Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing," Mandaviya said. Government sources said Uzbek officials reached out to India on Thursday night regarding the cough syrup-linked deaths and seeking a thorough probe in the matter. A legal representative of the company had said on Thursday that the manufacturing of Dok-1 Max has stopped "for now". Marion Biotech does not sell Dok-1 Max in India and its only export has been to Uzbekistan, a

All manufacturing activities at Marion Biotech's Noida unit have been stopped in view of reports of contamination of its cough syrup Dok-1 Max, Union Health Minister Mansukh Mandaviya said on Friday. Further investigation in connection with the death of 18 children in Uzbekistan allegedly linked to the cough syrup is going on, he said in a tweet. "Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing," Mandaviya said. The company's legal representative had said on Thursday that the manufacture of Dok-1 Max has stopped "for now". Mandaviya had said Thursday that further action would be taken based on the inspection of the pharma company. Marion Biotech does not sell Dok-1 Max in India and its only export has been to Uzbekistan, an Uttar Pradesh government official had said. Samples of the cough s

Cough syrup maker linked to Uzbekistan deaths halts production; samples of Dok-1 Max sent for analysis

According to the ministry, chemical ethylene glycol was found in a batch of syrup during laboratory tests

Business Standard brings you the top headlines at this hour

Noida-based Marion Biotech's Dok-1 Max anti-cold medicine under scanner after the Central Asian nation blames it for 18 deaths